Metabolic acidosis in AIDS patients.

[1]  R. Bellomo,et al.  Classification of acute kidney injury using RIFLE: What's the purpose? , 2007, Critical care medicine.

[2]  S. Knight,et al.  A high incidence of nucleoside reverse transcriptase inhibitor (NRTI)-induced lactic acidosis in HIV-infected patients in a South African context. , 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[3]  Gilles Clermont,et al.  RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis , 2006, Critical care.

[4]  A. E. El Nahas,et al.  The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability. , 2005, American Journal of Kidney Diseases.

[5]  P. Soentjens,et al.  Symptomatic hyperlactataemia and lactic acidosis in the era of highly active antiretroviral therapy. , 2005, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[6]  G. McComsey,et al.  Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival. , 2005, Infectious disease clinics of North America.

[7]  J. Weedon,et al.  Prognostic factors in lactic acidosis syndrome caused by nucleoside reverse transcriptase inhibitors: report of eight cases and review of the literature. , 2004, AIDS patient care and STDs.

[8]  M. Tagliati,et al.  Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy , 1995, Acta Neuropathologica.

[9]  B. Roca.  Trastornos metabólicos relacionados con el VIH y el tratamiento antirretroviral , 2003 .

[10]  V. Soriano,et al.  Toxicidad mitocondrial de los antirretrovirales: diagnóstico y monitorización , 2003 .

[11]  B. Dastugue,et al.  Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients. , 2003, Clinical chemistry.

[12]  J. Chiche,et al.  Bench-to-bedside review: Severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors , 2003, Critical care.

[13]  I. Weller,et al.  Lactic acidosis in HIV infected patients: a systematic review of published cases , 2002, Sexually transmitted infections.

[14]  R. Gherardi,et al.  Hyperlactatemia and Human Immunodeficiency Virus Infection: Lessons from the Era of Antiretroviral Monotherapy , 2002, Antimicrobial Agents and Chemotherapy.

[15]  M. Battegay,et al.  Lipodystrophy Syndrome by HAART in HIV-Infected Patients: Manifestation, Mechanisms and Management , 2002, Infection.

[16]  B. Gazzard,et al.  Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors , 2002, AIDS.

[17]  J. Miro,et al.  Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  V. Johnson,et al.  Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Alex J White,et al.  Mitochondrial toxicity and HIV therapy , 2001, Sexually transmitted infections.

[20]  K. Miller,et al.  Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases , 2000, Annals of Internal Medicine.

[21]  S. Alkhuja,et al.  Steatosis-lactic acidosis syndrome associated with stavudine and lamivudine therapy. , 2000, AIDS.

[22]  A. Marra,et al.  Lactic acidosis and antiretroviral therapy: a case report and literature review. , 2000, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[23]  B. Mégarbane,et al.  [Lactic acidosis and multi-organ failure secondary to anti-retroviral therapy in HIV-infected patients]. , 1999, Presse medicale.

[24]  P. Roy,et al.  Severe lactic acidosis induced by nucleoside analogues in an HIV-infected man. , 1999, Annals of emergency medicine.

[25]  E. Grimsley,et al.  Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient. , 1999, Southern medical journal.

[26]  J. Shapiro,et al.  Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. , 1997, Critical care medicine.

[27]  H. Scholte,et al.  Mitochondrial Injury , 1997, Drug safety.

[28]  R. Manfro,et al.  [Hydroelectrolyte, acid-base, and renal function changes in patients with acquired immunodeficiency syndrome]. , 1993, Revista da Associacao Medica Brasileira.

[29]  A. Arieff,et al.  Lactic Acidosis Complicating the Acquired Immunodeficiency Syndrome , 1993, Annals of Internal Medicine.

[30]  K. K. Lai,et al.  Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI). , 1991, Annals of internal medicine.